SureTrader
Interactive Brokers Advertisement
Home > Boards > Free Zone > User's Groups > Marijuana - Public Weed Stocks & Analysis (WEED)

$GWPH Daily - GW Pharmaceuticals plc is a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DollarsOnPennies Member Profile
Member Level 
Followed By 261
Posts 428,378
Boards Moderated 3
Alias Born 05/14/10
160x600 placeholder
DollarsOnPennies Member Level  Friday, 10/06/17 02:42:46 AM
Re: None
Post # of 32520 
$GWPH Daily - GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 27 countries outside the United States. Sativex is also in Phase 3 clinical development as a potential treatment of pain associated with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW is also advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex(R), which is in Phase 2/3 clinical development for the treatment of Dravet syndrome and which is also expected to enter Phase 3 clinical trials in the treatment of Lennox-Gastaut syndrome. GW has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type 2 diabetes, and schizophrenia.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist